Tilray Brands, Inc. (TLRY) Stock Price, Financials & Summary

Price chart

Aug 25Aug 28Sep 2Sep 8Sep 11Sep 16Sep 21Sep 24

Key dataSep 24, 2026

Open$4.09

From 52W high−80.62%

Volume2.33M

Market cap$571.52M

P/E (TTM)—

P/S (TTM)0.5x

Div yield—

Key dataSep 24, 2026

Open

$4.09

From 52W high

−80.62%

Volume

2.33M

Market cap

$571.52M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

44.4x

P/E (TTM)

—

RSI (14)

43.1

MomentumView details →

1D Return

−0.97%

YTD Return

−54.54%

SummaryUpdated May 1, 2026

Tilray Brands, Inc. (NASDAQ:TLRY) is a Canadian multinational cannabis and consumer packaged goods company founded in 2013 and headquartered in Leamington, Ontario. Originally established as a medical cannabis producer, Tilray went public in 2018 and has since transformed into a diversified lifestyle brands company through strategic acquisitions and international expansion. The company operates across four main business segments: cannabis, beverage alcohol, distribution, and wellness products, serving markets in over 20 countries including Canada, the United States, Europe, Australia, and Latin America.

Ask drillr about Tilray Brands, Inc. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

44.4x

EV/Sales

0.6x

P/S (TTM)

0.5x

P/B (TTM)

0.4x

ProfitabilityView details →

Gross Margin

27.57%

Net Margin

−12.90%

EBITDA Margin

1.40%

ROE (TTM)

−9.23%

ROA (TTM)

−6.40%

Asset Turnover

0.52x

GrowthView details →

Revenue YoY

+1.24%

EPS YoY

+95.87%

FCF YoY

+34.84%

Revenue CAGR 3Y

+2.72%

EPS CAGR 3Y

+96.78%

EBITDA YoY

+100.55%

MomentumView details →

1D Return

−0.97%

YTD Return

−54.54%

1Y Return

−65.50%

RSI (14)

43.1

vs 50D SMA

−6.02%

vs 200D SMA

−35.18%

Capital & dividendView details →

Debt/Equity

0.25x

Current Ratio

2.21x

Quick Ratio

1.37x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.43

EPS Surprise

−3471.43%

Beats (12Q)

2/12

Next Q EPS Est

−$0.17

Avg Surprise (4Q)

−909.32%

Rev Surprise

14.38%

Financials snapshotView financials →

Revenue (TTM)

1.16B

Net Income (TTM)

−149.05M

Op. CF (TTM)

−73.39M

Next earningsOct 8, 2026 →

Latest newsMore news →

BrewDog launched its 'Under New Ownership' campaign to mark a new era under Tilray ownership, highlighting fresh investment and its award-winning beers.2d ago

BrewDog's retail arm entered administration, with administrators AlixPartners reporting insufficient funds to pay employee wage arrears and preferential creditors.6d ago

Similar companies

Fusen Pharmaceutical Company Limited01652.HK Evotec SEEVO Aquestive Therapeutics, Inc.AQST Zhongzhi Pharmaceutical Holdings Limited03737.HK Evolus, Inc.EOLS Kamada Ltd.KMDA Find similar companies →

Latest newsMore news →

BrewDog launched its 'Under New Ownership' campaign to mark a new era under Tilray ownership, highlighting fresh investment and its award-winning beers.2d ago BrewDog's retail arm entered administration, with administrators AlixPartners reporting insufficient funds to pay employee wage arrears and preferential creditors.6d ago Brewdog's remaining operations entered administration after its bars and brewing facilities were sold to Tilray Brands for £30m in March, with administrators AlixPartners reporting creditor shortfalls.7d ago